Neurological assessment tool for screening infants during the first year after birth: The Brief-Hammersmith Infant

Domenico M Romeo1,2, Chiara Velli1, Francesca Sini1

  • 1Paediatric Neurology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Insights

A new short version of the Hammersmith Infant Neurological Examination (HINE), called Brief-HINE, effectively screens for cerebral palsy (CP) in infants. This tool demonstrates good accuracy and predictive power for early detection of CP.

Area of Science:

  • Pediatric neurology
  • Developmental pediatrics
  • Clinical assessment tools

Background:

  • The Hammersmith Infant Neurological Examination (HINE) is a comprehensive tool for assessing infant neurological development.
  • A shorter, more accessible screening tool is needed for routine clinical practice to identify infants at risk of cerebral palsy (CP).

Purpose of the Study:

  • To develop a brief version of the HINE (Brief-HINE) for infant screening.
  • To evaluate the accuracy and predictive power of the Brief-HINE for detecting cerebral palsy (CP).

Main Methods:

  • Eleven key items from the original HINE, identified as predictive of CP, were selected.
  • The Brief-HINE was applied to existing data from infants assessed at 3, 6, 9, and 12 months of age.
  • Data included infants with typical development and those who later developed CP.

Main Results:

  • The Brief-HINE demonstrated good sensitivity and specificity in detecting CP across all assessed ages.
  • Specific cut-off scores at 3, 6, 9, and 12 months showed high accuracy (e.g., sensitivity of 0.88-1.00, specificity of 0.81-0.92).
  • The presence of multiple warning signs on the Brief-HINE indicates a need for full HINE reassessment.

Conclusions:

  • The Brief-HINE is a valid and reliable screening method for infants.
  • Findings support the use of the Brief-HINE in routine clinical practice for early CP detection.
Abstract

Related Concept Videos